Quantification of plasma mutant calreticulin for diagnosis and therapeutic response assessment of peginterferon-α in myeloproliferative neoplasms: A proof-of-concept studyon January 6, 2026 at 10:49 am

January 6, 2026 by ccinfoadmin

Publication date: 15 February 2026

Source: Clinica Chimica Acta, Volume 582

Author(s): Jingjing Tian, Xuemei Tang, Weiyan Zhou, Can Yang, Qingyun Zhang, Quanli Wu, Xiaotong Ma, Gusheng Tang, Ming Guan, Zhiyuan Wu

301 Moved Permanently